Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 2
2006 pubmed

Expression and purification of a recombinant LL-37 from Escherichia coli.

Moon. Ja-Young JY; Henzler-Wildman. Katherine A KA; Ramamoorthy. A A

Key Findings

  • A GST‑LL‑37 fusion protein can be expressed in E. coli with a yield of about 8 mg per liter of culture
  • After cleavage with Factor Xa and purification by reverse‑phase HPLC, the final LL‑37 peptide yield is ~0.3 mg per liter
  • The system works in 15N‑labeled minimal medium, enabling production of isotopically labeled peptide for NMR studies

Practical Outcomes

  • The protocol provides a blueprint for producing LL‑37 in a lab, but it requires cloning, bacterial fermentation, enzyme cleavage, and HPLC equipment. It’s useful for advanced biohackers who have access to a molecular‑biology lab, but not a ready‑to‑use supplement or dosage guide for most users.

Summary

Scientists figured out a lab method to make the immune‑boosting peptide LL‑37 in bacteria and pull it out in a pure form, even adding special nitrogen labels for detailed studies. The process uses a GST tag, a specific enzyme cut, and high‑pressure liquid chromatography, giving modest amounts of peptide. For DIY bio‑enthusiasts it shows that making LL‑37 is possible, but the steps need a fully equipped molecular‑biology setup, so it isn’t a quick home‑brew recipe.

Abstract

Human cathelicidin-derived LL-37 is a 37-residue cationic, amphipathic alpha-helical peptide. It is an active component of mammalian innate immunity. LL-37 has several biological functions including a broad spectrum of antimicrobial activities and LPS-neutralizing activity. In order to determine the high-resolution three-dimensional structure of LL-37 using NMR spectroscopy, it is important to obtain the peptide with isotopic labels such as (15)N, (13)C and/or (2)H. Since it is less expensive to obtain such a peptide biologically, in this study, we report for the first time a method to express in E. coli and purify LL-37 using Glutathione S-transferase (GST) fusion system. LL-37 gene was inserted into vector pGEX-4T3 and expressed as a GST-LL-37 fusion protein in BL21(DE3) strain. The recombinant GST-LL-37 protein was purified with a yield of 8 mg/l by affinity chromatography and analyzed its biochemical and spectroscopic properties. Factor Xa was used to cleave a 4.5-kDa LL-37 from the GST-LL-37 fusion protein and the peptide was purified using a reverse-phase HPLC on a Vydac C(18) column with a final yield of 0.3 mg/l. The protein purified using reverse-phase HPLC was confirmed to be LL-37 by the analyses of Western blot and MALDI-TOF-Mass spectrometry. E. coli cells harboring the expression vector pGEX-4T3-LL-37 were grown in the presence of the (15)N-labeled M9 minimal medium and culture conditions were optimized to obtain uniform (15)N enrichment in the constitutively expressed LL-37 peptide. These results suggest that our production method will be useful in obtaining a large quantity of recombinant LL-37 peptide for NMR studies.

Study Information

Provider

pubmed

Year

2006

Date

2006-02-28T00:00:00.000Z

DOI

10.1016/j.bbamem.2006.02.003